Exane Derivatives Quidel Ortho Corp Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Quidel Ortho Corp stock. As of the latest transaction made, Exane Derivatives holds 7 shares of QDEL stock, worth $286. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7Holding current value
$286% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding QDEL
# of Institutions
293Shares Held
67.9MCall Options Held
337KPut Options Held
134K-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.4MShares$385 Million0.26% of portfolio
-
Carlyle Group Inc. Washington, DC8.26MShares$339 Million56.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.05MShares$248 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.89MShares$201 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY4.2MShares$172 Million5.33% of portfolio
About QuidelOrtho Corp
- Ticker QDEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 66,952,900
- Market Cap $2.74B
- Description
- QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...